{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:15:41Z","timestamp":1794006941369,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41440-025-02271-3","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T03:37:05Z","timestamp":1750995425000},"page":"2349-2357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Urinary cortisol-to-cortisone ratio levels modify the association between diabetes and hypertension: a cross-sectional study of 6931 older adults"],"prefix":"10.1038","volume":"48","author":[{"given":"Chisato","family":"Shimanoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Sogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Nanri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuki","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"2271_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41440-022-01087-9","volume":"46","author":"K Kario","year":"2023","unstructured":"Kario K, Tomitani N, Nishizawa M, Harada N, Kanegae H, Hoshide S. Concept, study design, and baseline blood pressure control status of the nationwide prospective HI-JAMP study using multisensor ABPM. Hypertens Res. 2023;46:357\u201367.","journal-title":"Hypertens Res"},{"key":"2271_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1758-5996-6-31","volume":"6","author":"P Lopez-Jaramillo","year":"2014","unstructured":"Lopez-Jaramillo P, Lopez-Lopez J, Lopez-Lopez C, Rodriguez-Alvarez MI. The goal of blood pressure in the hypertensive patient with diabetes is defined: now the challenge is go from recommendations to practice. Diabetol Metab Syndr. 2014;6:31.","journal-title":"Diabetol Metab Syndr"},{"key":"2271_CR3","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1161\/01.HYP.38.3.e11","volume":"38","author":"FH Messerli","year":"2001","unstructured":"Messerli FH, Grossman E. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;38:E11.","journal-title":"Hypertension"},{"key":"2271_CR4","doi-asserted-by":"crossref","unstructured":"Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43: S135\u2013S51.","DOI":"10.2337\/dc20-S011"},{"key":"2271_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","volume":"63","author":"JB Buse","year":"2020","unstructured":"Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2020;63:221\u20138.","journal-title":"Diabetologia"},{"key":"2271_CR6","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1681\/ASN.2009070737","volume":"20","author":"UF Mehdi","year":"2009","unstructured":"Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD. Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy. J Am Soc Nephrol. 2009;20:2641\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"2271_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ajh.2011.245","volume":"25","author":"H Shibata","year":"2012","unstructured":"Shibata H, Itoh H. Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension. Am J Hypertens. 2012;25:514\u201323.","journal-title":"Am J Hypertens"},{"key":"2271_CR8","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N. Engl J Med. 2020;383:2219\u201329.","journal-title":"N. Engl J Med"},{"key":"2271_CR9","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, et al. Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N. Engl J Med. 2021;385:2252\u201363.","journal-title":"N. Engl J Med"},{"key":"2271_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/dom.15327","volume":"26","author":"C Solis-Herrera","year":"2024","unstructured":"Solis-Herrera C, Triplitt C. Non-steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes. Diabetes Obes Metab. 2024;26:417\u201330.","journal-title":"Diabetes Obes Metab"},{"key":"2271_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","volume":"62","author":"P Anagnostis","year":"2013","unstructured":"Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M, et al. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Metabolism. 2013;62:21\u201333.","journal-title":"Metabolism"},{"key":"2271_CR12","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbadis.2009.10.017","volume":"1802","author":"P Ferrari","year":"2010","unstructured":"Ferrari P. The role of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human hypertension. Biochim Biophys Acta Mol Basis Dis. 2010;1802:1178\u201387.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2271_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/ajh\/hpy120","volume":"31","author":"M Buonafine","year":"2018","unstructured":"Buonafine M, Bonnard B, Jaisser F. Mineralocorticoid Receptor and Cardiovascular Disease. Am J Hypertens. 2018;31:1165\u201374.","journal-title":"Am J Hypertens"},{"key":"2271_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cca.2013.08.022","volume":"426","author":"J Zhang","year":"2013","unstructured":"Zhang J, Li J, Xu Y, Yang J, Chen Z, Deng H. Characteristics of novel hair-based biomarker for the activity assessment of 11\u03b2-hydroxysteroid dehydrogenase. Clin Chim Acta. 2013;426:25\u201332.","journal-title":"Clin Chim Acta"},{"key":"2271_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/bmc.877","volume":"21","author":"OA Sharef","year":"2007","unstructured":"Sharef OA, Feely J, Kavanagh PV, Scott KR, Sharma SC. An HPLC method for the determination of the free cortisol\/cortisone ratio in human urine. Biomed Chromatogr. 2007;21:1201\u20136.","journal-title":"Biomed Chromatogr"},{"key":"2271_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.steroids.2016.12.008","volume":"118","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Chen Z, Chen S, Xu Y, Deng H. Intraindividual stability of cortisol and cortisone and the ratio of cortisol to cortisone in saliva, urine and hair. Steroids. 2017;118:61\u20137.","journal-title":"Steroids"},{"key":"2271_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jchromb.2017.04.031","volume":"1057","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Shimanoe C, Tanaka K, Ichiba M, Hara M. Development of suitable method for large-scale urinary glucocorticoid analysis by liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2017;1057:62\u20139.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"2271_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.105125","volume":"125","author":"C Shimanoe","year":"2021","unstructured":"Shimanoe C, Matsumoto A, Hara M, Akao C, Nishida Y, Horita M, et al. Perceived stress, depressive symptoms, and cortisol-to-cortisone ratio in spot urine in 6878 older adults. Psychoneuroendocrinology. 2021;125:105125.","journal-title":"Psychoneuroendocrinology"},{"key":"2271_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2188\/jea.JE20090062","volume":"20","author":"M Hara","year":"2010","unstructured":"Hara M, Higaki Y, Imaizumi T, Taguchi N, Nakamura K, Nanri H, et al. Factors influencing participation rate in a baseline survey of a genetic cohort in Japan. J Epidemiol. 2010;20:40\u20135.","journal-title":"J Epidemiol"},{"key":"2271_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2188\/jea.JE20140116","volume":"25","author":"M Hara","year":"2015","unstructured":"Hara M, Shimanoe C, Otsuka Y, Nishida Y, Nanri H, Horita M, et al. Factors associated with non-participation in a face-to-face second survey conducted 5 years after the baseline survey. J Epidemiol. 2015;25:117\u201325.","journal-title":"J Epidemiol"},{"key":"2271_CR21","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/HYP.0000000000000087","volume":"73","author":"P Muntner","year":"2019","unstructured":"Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, et al. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019;73:e35\u201366.","journal-title":"Hypertension"},{"key":"2271_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1079\/BJN20031033","volume":"91","author":"H Kumahara","year":"2004","unstructured":"Kumahara H, Schutz Y, Ayabe M, Yoshioka M, Yoshitake Y, Shindo M, et al. The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br J Nutr. 2004;91:235\u201343.","journal-title":"Br J Nutr"},{"key":"2271_CR23","volume-title":"Fifth Revision of the Recommended Dietary Allowances for Japanese","author":"Health Promotion and Nutrition Division HSB, Ministry of Health and Welfare of Japan.","year":"1994","unstructured":"Health Promotion and Nutrition Division HSB, Ministry of Health and Welfare of Japan. Fifth Revision of the Recommended Dietary Allowances for Japanese. Tokyo: Daiichi Syuppan; 1994."},{"key":"2271_CR24","doi-asserted-by":"crossref","unstructured":"Fujimoto S, Watanabe T, Sakamoto A, Yukawa K, Morimoto K. Studies on the physical surface area of Japanese. Nihon Eiseigaku Zasshi. 1968;23:443\u201350. 18. Calculation formulas in three stages over all ages].","DOI":"10.1265\/jjh.23.443"},{"key":"2271_CR25","first-page":"40","volume":"5","author":"S Tokudome","year":"2004","unstructured":"Tokudome S, Goto C, Imaeda N, Tokudome Y, Ikeda M, Maki S. Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese. Asian Pac J Cancer Prev. 2004;5:40\u20133.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2271_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1053\/meta.2001.24213","volume":"50","author":"M Homma","year":"2001","unstructured":"Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, et al. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone\/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure. Metabolism. 2001;50:801\u20134.","journal-title":"Metabolism"},{"key":"2271_CR27","first-page":"748","volume":"76","author":"PM Stewart","year":"1993","unstructured":"Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J Clin Endocrinol Metab. 1993;76:748\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"2271_CR28","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510\u201326.","journal-title":"Circulation"},{"key":"2271_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41440-022-01036-6","volume":"46","author":"R Jo","year":"2023","unstructured":"Jo R, Shibata H, Kurihara I, Yokota K, Kobayashi S, Murai-Takeda A, et al. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertens Res. 2023;46:19\u201331.","journal-title":"Hypertens Res"},{"key":"2271_CR30","doi-asserted-by":"crossref","unstructured":"Liu X, Jiang J, Liu X, Luo Z, Wang Y, Dong X, et al. Gender-specific independent and combined effects of the cortisol-to-cortisone ratio and 11-deoxycortisol on prediabetes and type 2 diabetes mellitus: From the henan rural cohort study. J Diabetes Res. 2019;4693817.","DOI":"10.1155\/2019\/4693817"},{"key":"2271_CR31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/HJH.0000000000003028","volume":"40","author":"Y Song","year":"2022","unstructured":"Song Y, Nie L, Wei D, Liu P, Fan K, Zhang L, et al. Serum cortisol-to-cortisone ratio and 11-deoxycortisol are associated with hypertension and blood pressure in Chinese rural population: A cross-sectional study. J Hypertens. 2022;40:432\u201340.","journal-title":"J Hypertens"},{"key":"2271_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/ajh\/hpx002","volume":"30","author":"L Ghazi","year":"2017","unstructured":"Ghazi L, Dudenbostel T, Hachem ME, Siddiqui M, Lin CP, Oparil S, et al. 11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension. Am J Hypertens. 2017;30:518\u201323.","journal-title":"Am J Hypertens"},{"key":"2271_CR33","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41440-020-0502-5","volume":"43","author":"Y Imai","year":"2020","unstructured":"Imai Y, Hirata T, Saitoh S, Ninomiya T, Miyamoto Y, Ohnishi H, et al. Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study. Hypertension Res. 2020;43:1437\u201344.","journal-title":"Hypertension Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02271-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02271-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02271-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:58:33Z","timestamp":1757203113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02271-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2271"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02271-3","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}